Skip to content

Screener

Eligibility screening

YL242 in Subjects With Advanced Solid Tumors

Sponsored by MediLink Therapeutics (Suzhou) Co., Ltd.Study detailsClinicalTrials.gov

7 US sites in CT, FL, MA, MI +2

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.